1. Home
  2. NXPL vs LSTA Comparison

NXPL vs LSTA Comparison

Compare NXPL & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • LSTA
  • Stock Information
  • Founded
  • NXPL 1997
  • LSTA 1980
  • Country
  • NXPL United States
  • LSTA United States
  • Employees
  • NXPL N/A
  • LSTA N/A
  • Industry
  • NXPL Telecommunications Equipment
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • NXPL Telecommunications
  • LSTA Health Care
  • Exchange
  • NXPL Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • NXPL 17.9M
  • LSTA 22.5M
  • IPO Year
  • NXPL N/A
  • LSTA N/A
  • Fundamental
  • Price
  • NXPL $0.73
  • LSTA $2.61
  • Analyst Decision
  • NXPL
  • LSTA Strong Buy
  • Analyst Count
  • NXPL 0
  • LSTA 1
  • Target Price
  • NXPL N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • NXPL 28.3K
  • LSTA 23.5K
  • Earning Date
  • NXPL 08-13-2025
  • LSTA 08-11-2025
  • Dividend Yield
  • NXPL N/A
  • LSTA N/A
  • EPS Growth
  • NXPL N/A
  • LSTA N/A
  • EPS
  • NXPL N/A
  • LSTA N/A
  • Revenue
  • NXPL $62,515,000.00
  • LSTA $1,000,000.00
  • Revenue This Year
  • NXPL N/A
  • LSTA N/A
  • Revenue Next Year
  • NXPL N/A
  • LSTA N/A
  • P/E Ratio
  • NXPL N/A
  • LSTA N/A
  • Revenue Growth
  • NXPL 19.36
  • LSTA N/A
  • 52 Week Low
  • NXPL $0.43
  • LSTA $1.87
  • 52 Week High
  • NXPL $2.30
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 63.26
  • LSTA 52.43
  • Support Level
  • NXPL $0.73
  • LSTA $2.34
  • Resistance Level
  • NXPL $0.85
  • LSTA $3.09
  • Average True Range (ATR)
  • NXPL 0.06
  • LSTA 0.25
  • MACD
  • NXPL 0.00
  • LSTA 0.01
  • Stochastic Oscillator
  • NXPL 69.95
  • LSTA 50.67

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: